Literature DB >> 24863855

High-probability features of primary aldosteronism may obviate the need for confirmatory testing without increasing false-positive diagnoses.

Gregory A Kline1, Janice L Pasieka, Adrian Harvey, Benny So, Val C Dias.   

Abstract

This retrospective review examined all primary aldosteronism (PA) adrenal vein sampling (AVS), diagnoses, and outcomes from an endocrine hypertension unit where confirmatory testing was abandoned in 2005 to determine the potential rate of false-positive diagnoses. Patients with outcome-verified PA (surgical patients) were compared with patients with high-probability PA (nonsurgical but high aldosterone-renin ratio, imaging abnormalities, and/or hypokalemia) or possible PA (nonsurgical, no features besides mild elevation of aldosterone-renin ratio, a potential false diagnosis of PA). Of 83 patients, 58% had unilateral PA and 42% had bilateral aldosteronism. Less than 3% of the cohort showed bilateral aldosteronism without hypokalemia or computed tomographic findings, potentially representing the false-positive PA diagnosis rate with omission of confirmatory tests in this population. In a hypertension referral unit enriched in high-probability PA cases and where high AVS success is achieved, omission of a PA confirmatory test yields a high rate of surgical diagnosis with few potential false-positive diagnoses. ©2014 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24863855      PMCID: PMC8031658          DOI: 10.1111/jch.12342

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  34 in total

1.  Captopril suppression: limitations for confirmation of primary aldosteronism.

Authors:  Christina Westerdahl; Anders Bergenfelz; Anders Isaksson; Stig Valdemarsson
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2011-01-27       Impact factor: 1.636

2.  Adrenal vein sampling may not be a gold-standard diagnostic test in primary aldosteronism: final diagnosis depends upon which interpretation rule is used. Variable interpretation of adrenal vein sampling.

Authors:  Gregory A Kline; Adrian Harvey; Charlotte Jones; Michael H Hill; Benny So; Nairne Scott-Douglas; Janice L Pasieka
Journal:  Int Urol Nephrol       Date:  2008-08-12       Impact factor: 2.370

3.  High prevalence of primary aldosteronism in the Tayside hypertension clinic population.

Authors:  P O Lim; E Dow; G Brennan; R T Jung; T M MacDonald
Journal:  J Hum Hypertens       Date:  2000-05       Impact factor: 3.012

4.  Comparison of the saline infusion test and the fludrocortisone suppression test for the diagnosis of primary aldosteronism.

Authors:  H S Willenberg; O Vonend; M Schott; X Gao; D Blondin; A Saleh; L C Rump; W A Scherbaum
Journal:  Horm Metab Res       Date:  2012-06-11       Impact factor: 2.936

5.  Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore.

Authors:  K C Loh; E S Koay; M C Khaw; S C Emmanuel; W F Young
Journal:  J Clin Endocrinol Metab       Date:  2000-08       Impact factor: 5.958

6.  Consequences of adrenal venous sampling in primary hyperaldosteronism and predictors of unilateral adrenal disease.

Authors:  Aarti Mathur; Clinton D Kemp; Utpal Dutta; Smita Baid; Alejandro Ayala; Richard E Chang; Seth M Steinberg; Vasilios Papademetriou; Eileen Lange; Steven K Libutti; James F Pingpank; H Richard Alexander; Giao Q Phan; Marybeth Hughes; W Marston Linehan; Peter A Pinto; Constantine A Stratakis; Electron Kebebew
Journal:  J Am Coll Surg       Date:  2010-07-14       Impact factor: 6.113

Review 7.  Prevalence of primary aldosteronism: should we screen for primary aldosteronism before treating hypertensive patients with medication?

Authors:  Tetsuo Nishikawa; Jun Saito; Masao Omura
Journal:  Endocr J       Date:  2006-11-24       Impact factor: 2.349

8.  A clinical prediction score to diagnose unilateral primary aldosteronism.

Authors:  Elselien M Küpers; Laurence Amar; Alain Raynaud; Pierre-François Plouin; Olivier Steichen
Journal:  J Clin Endocrinol Metab       Date:  2012-08-23       Impact factor: 5.958

9.  Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma.

Authors:  Gian Paolo Rossi; Anna Belfiore; Giampaolo Bernini; Giovambattista Desideri; Bruno Fabris; Claudio Ferri; Gilberta Giacchetti; Claudio Letizia; Mauro Maccario; Francesca Mallamaci; Massimo Mannelli; Gaetana Palumbo; Damiano Rizzoni; Ermanno Rossi; Enrico Agabiti-Rosei; Achille C Pessina; Franco Mantero
Journal:  Hypertension       Date:  2007-06-25       Impact factor: 10.190

10.  Statistics review 13: receiver operating characteristic curves.

Authors:  Viv Bewick; Liz Cheek; Jonathan Ball
Journal:  Crit Care       Date:  2004-11-04       Impact factor: 9.097

View more
  13 in total

Review 1.  Primary aldosteronism: a common cause of resistant hypertension.

Authors:  Gregory A Kline; Ally P H Prebtani; Alexander A Leung; Ernesto L Schiffrin
Journal:  CMAJ       Date:  2017-06-05       Impact factor: 8.262

2.  Adrenal Vein Sampling Lateralization Despite Mineralocorticoid Receptor Antagonists Exposure in Primary Aldosteronism.

Authors:  Aya T Nanba; Taweesak Wannachalee; James J Shields; James B Byrd; William E Rainey; Richard J Auchus; Adina F Turcu
Journal:  J Clin Endocrinol Metab       Date:  2019-02-01       Impact factor: 5.958

3.  A Multi-institutional Comparison of Adrenal Venous Sampling in Patients with Primary Aldosteronism: Caution Advised if Successful Bilateral Adrenal Vein Sampling is Not Achieved.

Authors:  Tracy S Wang; Greg Kline; Tina W Yen; Ziyan Yin; Ying Liu; William Rilling; Benny So; James W Findling; Douglas B Evans; Janice L Pasieka
Journal:  World J Surg       Date:  2018-02       Impact factor: 3.352

4.  Performance of Confirmatory Tests for Diagnosing Primary Aldosteronism: a Systematic Review and Meta-Analysis.

Authors:  Alexander A Leung; Christopher J Symonds; Gregory L Hundemer; Paul E Ronksley; Diane L Lorenzetti; Janice L Pasieka; Adrian Harvey; Gregory A Kline
Journal:  Hypertension       Date:  2022-06-02       Impact factor: 9.897

5.  Primary aldosteronism: from case detection to histopathology with up to 6 years of follow-up.

Authors:  Gudbjörg Jonsdottir; Jon Gudmundsson; Gudjon Birgisson; Helga Agusta Sigurjonsdottir
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-11-23       Impact factor: 3.738

6.  Unadjusted Plasma Renin Activity as a "First-Look" Test to Decide Upon Further Investigations for Primary Aldosteronism.

Authors:  Peter Rye; Alex Chin; Janice Pasieka; Benny So; Adrian Harvey; Gregory Kline
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-03-10       Impact factor: 3.738

7.  Screening for Primary Aldosteronism: Whom and How?

Authors:  Michael Doumas; Vasilios Athyros; Vasilios Papademetriou
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-03-10       Impact factor: 3.738

8.  Surgical Outcomes Among Primary Aldosteronism Patients Without Visible Adrenal Lesions.

Authors:  Davis Sam; Gregory A Kline; Benny So; Janice L Pasieka; Adrian Harvey; Alex Chin; Stefan J Przybojewski; Alexander A Leung
Journal:  J Clin Endocrinol Metab       Date:  2021-01-23       Impact factor: 5.958

9.  Repeat Adrenal Vein Sampling in Aldosteronism: Reproducibility and Interpretation of Persistently Discordant Results.

Authors:  Gregory A Kline; Alexander Ah-Chi Leung; Davis Sam; Alex Chin; Benny So
Journal:  J Clin Endocrinol Metab       Date:  2021-03-08       Impact factor: 5.958

10.  A single-step approach to the diagnosis of primary hyperaldosteronism: filling a true void or burdening the bottleneck of adrenal vein sampling?

Authors:  Etty Osher; Yonit Marcus; Naftali Stern
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-05-23       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.